World's Best Scientists 2026 revealed!
Evangelos J. Giamarellos-Bourboulis

Evangelos J. Giamarellos-Bourboulis

Award Badge
Microbiology
Greece
2023

D-Index & Metrics

Microbiology

D-Index
83
Citations
30861
World Ranking
966
National Ranking
6

Medicine

D-Index
88
Citations
34866
World Ranking
13000
National Ranking
33

Evangelos J. Giamarellos-Bourboulis publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Evangelos J. Giamarellos-Bourboulis sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 426 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Evangelos J. Giamarellos-Bourboulis D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Evangelos J. Giamarellos-Bourboulis sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 83 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Microbiology in Greece Leader Award
  • 2022 - Research.com Microbiology in Greece Leader Award

Overview

Evangelos J. Giamarellos-Bourboulis is affiliated with the National and Kapodistrian University of Athens in Greece. Their research contributions primarily lie within the field of Medicine, with significant subfields including Epidemiology, Infectious Diseases, Immunology, Surgery, and Dermatology.

The scientist's work covers several main topics, such as:

  • Sepsis Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Hidradenitis Suppurativa and Treatments
  • Long-Term Effects of COVID-19
  • Colorectal and Anal Carcinomas
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory Support and Mechanisms

They have contributed to multiple recent papers, notable examples include:

  • Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure, 2020, Cell Host & Microbe
  • Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly, 2020, Cell

Frequent coauthors in their research projects are:

  • Mihai G. Netea
  • Georgia Damoraki
  • Evdoxia Kyriazopoulou
  • Karolina Akinosoglou
  • Nikolaos Antonakos

The scientist has published extensively in several venues, with the most frequent being:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Critical Care
  • British Journal of Dermatology
  • Shock

Best Publications

  • mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity

    Shih-Chin Cheng;Jessica Quintin;Robert A. Cramer;Kelly M. Shepardson

  • COMPLEX IMMUNE DYSREGULATION IN COVID-19 PATIENTS WITH SEVERE RESPIRATORY FAILURE

    Evangelos J. Giamarellos-Bourboulis;Mihai G. Netea;Mihai G. Netea;Nikoletta Rovina;Karolina Akinosoglou

  • Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity

    Sadia Saeed;Jessica Quintin;Hindrik H. D. Kerstens;Nagesha A. Rao

  • Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes

    Jessica Quintin;Sadia Saeed;Joost H.A. Martens;Evangelos J. Giamarellos-Bourboulis

  • A guiding map for inflammation

    Mihai G Netea;Frances Balkwill;Michel Chonchol;Fabio Cominelli

  • Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

    Alexa B Kimball;Martin M Okun;David A Williams;Alice B Gottlieb

  • Azithromycin: mechanisms of action and their relevance for clinical applications.

    Michael J. Parnham;Michael J. Parnham;Vesna Erakovic Haber;Evangelos J. Giamarellos-Bourboulis;Gianpaolo Perletti;Gianpaolo Perletti

  • Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis

    Shih Chin Cheng;Brendon P. Scicluna;Rob J W Arts;Mark S. Gresnigt

  • The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.

    Marcin F. Osuchowski;Martin S. Winkler;Tomasz Skirecki;Sara Cajander

  • Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.

    Mihai G. Netea;Mihai G. Netea;Evangelos J. Giamarellos-Bourboulis;Jorge Domínguez-Andrés;Nigel Curtis

  • Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

    Evdoxia Kyriazopoulou;Garyfallia Poulakou;Haralampos Milionis;Simeon Metallidis

  • Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016

    R. M. Bateman;M. D. Sharpe;J. E. Jagger;C. G. Ellis

  • Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.

    C. C. Zouboulis;T. Tzellos;A. Kyrgidis;G. B. E. Jemec

  • Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

    Richard G. Wunderink;Evangelos J. Giamarellos-Bourboulis;Galia Rahav;Amy J. Mathers

  • What causes hidradenitis suppurativa

    H Kurzen;I Kurokawa;G B E Jemec;L Emtestam

  • Carrier Systems for the Local Delivery of Antibiotics in Bone Infections

    Kyriaki Kanellakopoulou;Evangelos J. Giamarellos-Bourboulis

  • TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans

    Bart Ferwerda;Matthew B. B. McCall;Santos Alonso;Evangelos J. Giamarellos-Bourboulis

  • Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly.

    Evangelos J. Giamarellos-Bourboulis;Maria Tsilika;Simone Moorlag;Nikolaos Antonakos

  • Engagement of fatty acids with toll‐like receptor 2 drives interleukin‐1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritis

    Leo A. B. Joosten;Mihai G. Netea;Eleni Mylona;Marije I. Koenders

  • Current gaps in sepsis immunology: new opportunities for translational research.

    Ignacio Rubio;Marcin F Osuchowski;Manu Shankar-Hari;Manu Shankar-Hari;Tomasz Skirecki

  • Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.

    Keith S. Kaye;Tanaya Bhowmick;Symeon Metallidis;Susan C. Bleasdale

Frequent Co-Authors

Helen Giamarellou
Helen Giamarellou National and Kapodistrian University of Athens
Mihai G. Netea
Mihai G. Netea Radboud University
Jos W. M. van der Meer
Jos W. M. van der Meer Radboud University Medical Center
Leo A. B. Joosten
Leo A. B. Joosten Radboud University
Frank L. van de Veerdonk
Frank L. van de Veerdonk Radboud University
George Dimopoulos
George Dimopoulos National and Kapodistrian University of Athens
Michael Bauer
Michael Bauer TU Dresden
Peter Pickkers
Peter Pickkers Radboud University
Charis Roussos
Charis Roussos National and Kapodistrian University of Athens
Jesper Eugen-Olsen
Jesper Eugen-Olsen Copenhagen University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options and advanced degrees that complement this field. For those interested in public health, exploring mph online programs with easy admission requirements can provide a faster pathway to gaining essential skills and expanding career opportunities.

Microbiology graduates may also consider health-related roles beyond the laboratory. For example, becoming a functional nurse practitioner is a growing field that blends medical knowledge with patient-centered care, ideal for those passionate about holistic health approaches.

For individuals with unique career challenges, such as those with past convictions, there are supportive educational paths. The what is the best degree for a convicted felon resource highlights accessible degrees that can help rebuild professional lives, proving education can be inclusive and empowering.

Additionally, those drawn to pediatric care and emotional support can explore careers as a certified child life specialist salary is competitive, reflecting the crucial role these professionals play in helping children cope with medical experiences.

In summary, Microbiology studies serve as a foundation for varied and rewarding online degrees and career pathways that suit different interests and circumstances.

Best Scientists Citing Evangelos J. Giamarellos-Bourboulis

Trending Scientists

Recently Published Articles